Incannex Healthcare Ltd Stock Fundamentals
| IXHL Stock | USD 1.78 0.04 2.20% |
Incannex Healthcare Ltd fundamentals help investors to digest information that contributes to Incannex Healthcare's financial success or failures. It also enables traders to predict the movement of Incannex Stock. The fundamental analysis module provides a way to measure Incannex Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Incannex Healthcare stock.
At this time, Incannex Healthcare's Selling And Marketing Expenses is quite stable compared to the past year. Tax Provision is expected to rise to about 31.5 K this year, although the value of Interest Expense will most likely fall to 2,576. Incannex | Select Account or Indicator |
Incannex Healthcare Ltd Company Operating Margin Analysis
Incannex Healthcare's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Incannex Healthcare Operating Margin | (538.33) % |
Most of Incannex Healthcare's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Incannex Healthcare Ltd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Incannex Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Incannex Healthcare Ltd has an Operating Margin of -538.3333%. This is much higher than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
Incannex Healthcare Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Incannex Healthcare's current stock value. Our valuation model uses many indicators to compare Incannex Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Incannex Healthcare competition to find correlations between indicators driving Incannex Healthcare's intrinsic value. More Info.Incannex Healthcare Ltd is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Incannex Healthcare's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Incannex Healthcare by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Incannex Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Incannex Healthcare's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Incannex Healthcare could also be used in its relative valuation, which is a method of valuing Incannex Healthcare by comparing valuation metrics of similar companies.Incannex Healthcare is currently under evaluation in operating margin category among its peers.
Incannex Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Incannex Healthcare from analyzing Incannex Healthcare's financial statements. These drivers represent accounts that assess Incannex Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Incannex Healthcare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.5B | 3.6B | 1.1B | 28.3M | 47.7M | 45.3M | |
| Enterprise Value | 2.5B | 3.6B | 1.1B | 6.7M | 42.2M | 40.1M |
Incannex Fundamentals
| Return On Equity | -1.15 | ||||
| Return On Asset | -0.57 | ||||
| Operating Margin | (538.33) % | ||||
| Current Valuation | 28.19 M | ||||
| Shares Outstanding | 17.64 M | ||||
| Shares Owned By Insiders | 25.86 % | ||||
| Shares Owned By Institutions | 4.13 % | ||||
| Number Of Shares Shorted | 27.53 K | ||||
| Price To Book | 4.76 X | ||||
| Price To Sales | 2,706 X | ||||
| Revenue | 12 K | ||||
| Gross Profit | 1.01 M | ||||
| EBITDA | (18.5 M) | ||||
| Net Income | (18.46 M) | ||||
| Cash And Equivalents | 37.5 M | ||||
| Cash Per Share | 0.68 X | ||||
| Total Debt | 373 K | ||||
| Current Ratio | 18.84 X | ||||
| Book Value Per Share | 0.64 X | ||||
| Cash Flow From Operations | (15.85 M) | ||||
| Short Ratio | 1.76 X | ||||
| Earnings Per Share | (1.36) X | ||||
| Beta | 2.21 | ||||
| Market Capitalization | 32.47 M | ||||
| Total Asset | 17.05 M | ||||
| Retained Earnings | (110.67 M) | ||||
| Working Capital | 10.58 M | ||||
| Net Asset | 17.05 M |
About Incannex Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Incannex Healthcare Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Incannex Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Incannex Healthcare Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 97.8 K | 82.9 K | |
| Total Revenue | 12 K | 11.4 K | |
| Stock Based Compensation To Revenue | 2.15 | 2.05 | |
| Sales General And Administrative To Revenue | 1.3 K | 1.3 K | |
| Research And Ddevelopement To Revenue | 965.93 | 1,014 | |
| Capex To Revenue | 20.78 | 21.81 | |
| Ebit Per Revenue | -2.9 K | -2.7 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Incannex Healthcare Piotroski F Score and Incannex Healthcare Altman Z Score analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.296 | Return On Assets (0.57) | Return On Equity (1.15) |
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.